Tag Archives: Breast cancer

Lilly Osteoporosis Drug Canned in Phase III Trials

Image by go elsewhere… via Flickr Lilly, on Wednesday, announced that it would not seek regulatory approval for its osteoporosis treatment arzoxifene, because the drug failed to meet certain end points in Phase III clinical trials. The good news is that the drug was successful in meeting the primary end point of the trial, dubbed […]
Posted in Strategy | Also tagged , , , , , | 1 Comment

Strategic Patient Adherence Awards: “And the Winners Are”

Pharm Exec was proud to partner this year with CBI on the eighth annual Forum on Patient Compliance, Adherence & Persistency. One of the highlights of the event is the presentation of the Strategic Patient Adherence Awards, which honor pharma-based programs to improve compliance. The winners this year: For best branded program AstraZeneca Canada for […]
Posted in Events | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta